FDA Inspection
Blossom PharmaceuticalsBlossom Pharmaceuticals – FDA Inspection, Dec 16, 2016
Record Details
This FDA Inspection record concerns Blossom Pharmaceuticals, with an inspection on December 16, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0a673663-2f3c-4f19-b939-a2864c6bb6c7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 998364
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Blossom Pharmaceuticals
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2025 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| February 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Blossom Pharmaceuticals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.